ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 59 filers reported holding ADAGIO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $43,860 | +61.9% | 25,800 | 0.0% | 0.03% | +7.1% |
Q2 2023 | $27,090 | -12.5% | 25,800 | 0.0% | 0.03% | +33.3% |
Q1 2023 | $30,960 | -20.0% | 25,800 | 0.0% | 0.02% | -36.4% |
Q4 2022 | $38,700 | -52.2% | 25,800 | 0.0% | 0.03% | -29.8% |
Q3 2022 | $81,000 | -4.7% | 25,800 | 0.0% | 0.05% | -39.7% |
Q2 2022 | $85,000 | -28.0% | 25,800 | 0.0% | 0.08% | -18.8% |
Q1 2022 | $118,000 | -36.9% | 25,800 | 0.0% | 0.10% | -16.5% |
Q4 2021 | $187,000 | – | 25,800 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 9,248,250 | $13,872,375 | 13.22% |
Alphabet Inc. | 5,680,785 | $8,521,178 | 0.50% |
683 Capital Management, LLC | 3,000,000 | $4,500,001 | 0.38% |
Bain Capital Life Sciences Investors, LLC | 1,937,207 | $2,906 | 0.32% |
Slate Path Capital LP | 3,735,000 | $5,602,500 | 0.30% |
Newtyn Management, LLC | 900,000 | $1,350,000 | 0.28% |
Orbimed Advisors | 5,270,400 | $7,905,600 | 0.15% |
Oasis Management Co Ltd. | 348,432 | $522,648 | 0.10% |
Redmile Group, LLC | 1,440,725 | $2,161,088 | 0.09% |
Anson Funds Management LP | 154,156 | $231,234 | 0.04% |